Indian origin scientist identifies four possible drugs to treat Covid-19
Team Udayavani, May 18, 2020, 1:24 PM IST
An Indian-origin researcher in the US and his team have identified four antiviral drugs to treat Covid-19.
The study, published in the journal Pathogens, found that all four drugs were effective in inhibiting or blocking, the coronavirus’ RNA proteins from making genomic copies of the novel coronavirus.
Kamlendra Singh, an associate professor at the University of Missouri in the US, and his colleagues used computer-aided drug design to examine the effectiveness of remdesivir, 5-fluorouracil, ribavirin and favipiravir in treating Covid-19
Researchers claim that the drugs, if they turn out to be effective might have some limitations. But they are worth taking a deeper look as these drugs could potentially be effective in treating Covid-19
The researchers also noted that SARS-CoV-2 that causes Covid-19, like all viruses, can mutate and develop resistance to antiviral drugs. It is said that, the drugs need to be further tested in a laboratory setting and in patients is evaluate how the proposed treatments interact with the virus’ RNA polymerase.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
December 21: Everything about the ‘Winter Solstice’
World Meditation Day 2024: Celebrating inner peace and well-being
Mangaluru: Vincent’s ‘Santa Claus’ ride marks 25 years of spreading Christmas cheer
I made him tabla, he made my life: Zakir Hussain’s tabla maker
Manipal-Konaje Knowledge and Health Corridor stuck in limbo
MUST WATCH
Latest Additions
Kannada Sahitya Sammelana: Food distribution creates stir
Rohit gets hit in nets, practice pitches on slower side
India & Kuwait elevate ties to strategic level; ink defence pact after PM Modi meets top Kuwaiti leaders
In Kuwait, PM Modi meets yoga practitioner, other influencers from Gulf country
Notorious gangster wanted in UAPA case arrested at Nepal border
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.